Time to End “Manels” in Clinical Trial Leadership

Time to End “Manels” in Clinical Trial Leadership

Young women hoping to pursue a career in academic cardiology face a broken pipeline. Nationally, women make up 21% of cardiology fellows, 17% of cardiology faculty, and 15% of cardiology journal editorial boards. Although representation of women in cardiology remain sparse at all levels, nowhere is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of internal medicine (1960) 2020-10, Vol.180 (10), p.1383-1384
Hauptverfasser: Wang, Tracy Y, DesJardin, Jacqueline Talea
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Clinical trials
Female
Humans
Leadership
University faculty
Women
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Young women hoping to pursue a career in academic cardiology face a broken pipeline. Nationally, women make up 21% of cardiology fellows, 17% of cardiology faculty, and 15% of cardiology journal editorial boards. Although representation of women in cardiology remain sparse at all levels, nowhere is their underrepresentation more apparent than at the top echelons of academia: clinical trial leadership.
ISSN:2168-6106
2168-6114
DOI:10.1001/jamainternmed.2020.2489